U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06810986) titled 'Cohort Study Evaluating Glycaemic Control in Individuals with Type 2 Diabetes Mellitus Through Digital Therapeutics (DM DTx)' on Jan. 31.
Brief Summary: This study is conducted to evaluate the effectiveness of Digital therapeutics (DTx) in managing patients with Type 2 Diabetes Mellitus (T2DM) by delivering digital lifestyle interventions through a national health application (BruHealth).
Study Start Date: Aug. 20, 2024
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes Mellitus (T2DM)
Intervention:
BEHAVIORAL: 16-week digital intervention
Participants will be enrolled in a 16-week programme with the aim to manage T2DM thro...